U.S. regulators have warned Johnson & Johnson unit Janssen Pharmaceutica that a letter sent to doctors about its Risperdal drug to treat schizophrenia and bipolar mania is misleading. In a warning disclosed on Tuesday, the Food and Drug Administration told Janssen that its …
Before posting, please read our blog moderation guidelines. The comments below begin with the oldest comments first. Click on the last comments page to jump to the most recent comments.
Before posting, please read our blog moderation guidelines.
Post a Comment:
I finally got a chance to check out your web page, and I must say that I’m impressed. Hope everything is going well. Take care!
I have tried practically every drug on the market including Risperdal. It’s funny how you are not told about side effects and when you are down, you can’t look it up because you just don’t care. I think psychiatrists in general need to be more forthcoming about side effects of meds. I gained a lot of weight on this drug.